InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2024-06-03 00:00:00 ET · period of report 2024-05-30 · accession 0001773751-24-000156 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-03 2024-05-30 HIMS Boughton Soleil CLO S - Sale+OE $20.55 -129.7K 156.9K -45% -$2.66M
D 2024-06-03 2024-05-30 HIMS Boughton Soleil CLO M - OptEx $5.01 +129.7K 286.5K +83% +$649.6K
D 2024-06-03 2024-05-30 HIMS Boughton Soleil CLO M - OptEx $0.00 -129.7K 834.4K -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-05-30 S D 114,460 $20.47 172,062 D — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Class A Common Stock 2024-05-30 M A 129,667 $5.01 286,522 D — —
3 Common Class A Common Stock 2024-05-30 S D 15,207 $21.17 156,855 D — — (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.00 - $21.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (right to buy) 2024-05-30 M D 129,667 $0.00 834,409 D $5.01 · — to 2032-02-23 129,667 Class A Common Stock (F4) The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.